secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2025-08-19T23:59:59+00:00
Accession:  0001140361-25-031828
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis enters non-binding LOI to acquire Rendiatech, an Israeli renal monitoring firm
--------------------------------------------------------------------------------

- Rendiatech specializes in real-time urine flow and acute kidney injury monitoring technologies.
- Acquisition intended to expand Nuwellis' platform beyond ultrafiltration into continuous renal health monitoring.
- Parties in due diligence; transaction expected to close in Q4 2025, pending board approval and conditions.
- No financial terms disclosed in the non-binding letter of intent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036125031828/0001140361-25-031828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036125031828/ef20054176_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-031828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer